Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jan 25, 2019
Rezūm patients experienced significant and sustained improvement in benign prostatic hyperplasia (BPH) symptoms and quality of life.
-
Jan 24, 2019Advanced systems offer customizable therapy addressing progression of Parkinson's disease
Advanced systems offer customizable therapy to treat Parkinson's symptoms.
-
Jan 22, 2019Results from the VIRTUS Study Show Venous Stent Met Its Primary Effectiveness and Safety Endpoints in Re-establishing Blood Flow at Twelve Months
Boston Scientific venous stent met VIRTUS trial primary effectiveness and safety endpoints in re-establishing blood flow.
-
Jan 15, 2019All Patent Litigation Between the Companies to be Dismissed
All patent litigation between the companies to be dismissed.
-
Jan 8, 2019
Boston Scientific will webcast its conference call with financial results and business highlights for Q4 2018 and the full 2018 year.
-
Jan 4, 2019
Boston Scientific will webcast its conference call discussing financial results and business highlights for Q4 ended December 31, 2018. Learn how to tune in.
-
Dec 27, 2018Acquisition will expand structural heart portfolio to include transcatheter mitral annuloplasty repair system
Acquisition will expand structural heart portfolio to include transcatheter mitral annuloplasty repair system
-
Dec 21, 2018
A live webcast and replay will be available. Learn how to tune in.
-
Dec 11, 2018Delaware Court Rules Edwards Lifesciences Infringes Boston Scientific Patent
Delaware court rules Edwards Lifesciences Infringes Boston Scientific patent
-
Dec 3, 2018
Boston Scientific will participate in a healthcare investor conference in December 2018. A live webcast and replay will be available.
-
Nov 27, 2018
Boston Scientific will participate in Citi’s healthcare investor conference in December 2018. A live webcast and replay will be available.
-
Nov 25, 2018
In helping care for people living with complex, debilitating and often life-threatening conditions, patient safety is Boston Scientific’s highest priority.
-
Nov 21, 2018
Boston Scientific will participate the healthcare investor conference in November 2018. A live webcast and replay will be available.
-
Nov 20, 2018Transaction would expand peripheral interventions portfolio with minimally-invasive treatments for cancers and vascular conditions
Transaction would expand Boston Scientific peripheral interventions portfolio with minimally invasive treatments for cancers and vascular conditions
-
Nov 7, 2018
Boston Scientific will participate in a medtech conference in November 2018. A live webcast and replay will be available.
-
Nov 6, 2018
Boston Scientific Corporation (NYSE: BSX) will participate in the Stifel 2018 Healthcare Conference on Tuesday, November 13, 2018 in New York City. Dan Brennan, executive vice president and chief...
-
Nov 6, 2018
Boston Scientific Corporation (NYSE: BSX) will participate in the 27th Annual Credit Suisse Healthcare Conference on Wednesday, November 14, 2018 in Scottsdale, Arizona. Joe Fitzgerald, executive...
-
Oct 24, 2018
"Through internal research and tuck-in acquisitions, we continue to bring meaningful innovations to market,” said CEO Mike Mahoney.
-
Oct 23, 2018Court Rules Edwards Lifesciences' Next-Generation Valve Infringes Boston Scientific Patent and Grants Right to Enjoin Sales in Germany
Court rules Edwards Lifesciences’ next-generation valve infringes Boston Scientific patent and grants right to enjoin sales in Germany.
-
Oct 16, 2018
The acquisition brings SpaceOAR, which decreases exposure to rectal radiation during prostate cancer radiotherapy, into the Boston Scientific portfolio.
-
Oct 10, 2018Data Support Minimally Invasive Single-Incision Mesh Procedure as a Durable, Safe and Effective Treatment for Stress Urinary Incontinence, a Condition that Affects 18 Million American Adults
Data support minimally invasive single-incision mesh procedure as a durable, safe and effective treatment for stress urinary incontinence.
-
Oct 1, 2018Fourth annual Connected Patient Challenge focuses on utilizing population health data, patient monitoring or predictive analytics to improve patient care and lower healthcare costs
4th annual Connected Patient Challenge focuses on using population health data, patient monitoring or predictive analytics to improve care and lower costs.
-
Oct 1, 2018
Boston Scientific will webcast its conference call with financial results and business highlights for Q3 ended September 30, 2018. Learn how to tune in.
-
Sep 24, 2018First peripheral vascular interventional technology approved in the U.S. to offer sustained release of antiproliferative drug to treat patients with peripheral artery disease
Eluvia is the first peripheral vascular interventional technology approved in U.S. to offer a sustained release of a drug to treat peripheral artery disease.
-
Sep 22, 2018First head-to-head trial assesses effectiveness of sustained drug release in interventional treatment for patients with blockages in femoropopliteal arteries
First head-to-head trial assesses effectiveness of sustained drug release in interventional treatment for patients with blockages in femoropopliteal arteries.